GSK3B and colorectal carcinoma: Since the CRC cells used in this study carry an APC mutation, preventing the formation of the APC/β-catenin multiprotein complex, it seems unlikely that the NSAID-induced decrease in nonphosphorylated β-catenin is regulated by GSK-3β activity.